As SARS-CoV-2 vaccinations are rolled out globally, acting as a light at the end of a rather bleak tunnel, doctors, government leaders and the public are asking themselves questions:
“How do we know the vaccine is working?”
Exec Chat: Adaptive Biotechnologies Will Use T Cells To Spot Prior Infections, Including COVID-19
Adaptive chief medical officer Lance Baldo talked to Medtech Insight about the company's plans to detect prior infection using T-cells obtained from blood samples.
